video thumbnail

Long COVID Improvement after Therapeutic Apheresis

{{isShortDescriptionLonger && !showFullDescription ? shortDescription.slice(0, 250) : shortDescription}}... See {{showFullDescription? 'less' : 'more'}}

Write A New Comment


This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte rouleaux formation after extracorporeal apheresis. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.

Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis | Molecular Psychiatry

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Recent Videos
Related Videos